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Abstract
Background: Bovine herpesvirus 4 (BoHV-4) is a useful model for the human pathogenic gammaherpesviruses
Epstein-Barr virus and Kaposi’s Sarcoma-associated Herpesvirus. Although genome manipulations of this virus have
been greatly facilitated by the cloning of the BoHV-4 V.test strain as a Bacterial Artificial Chromosome (BAC), the
lack of a complete genome sequence for this strain limits its experimental use.
Methods: In this study, we have determined the complete sequence of BoHV-4 V.test strain by a pyrosequencing approach.
Results: The long unique coding region (LUR) consists of 108,241 bp encoding at least 79 open reading frames
and is flanked by several polyrepetitive DNA units (prDNA). As previously suggested, we showed that the prDNA
unit located at the left prDNA-LUR junction (prDNA-G) differs from the other prDNA units (prDNA-inner). Namely,
the prDNA-G unit lacks the conserved pac-2 cleavage and packaging signal in its right terminal region. Based on
the mechanisms of cleavage and packaging of herpesvirus genomes, this feature implies that only genomes
bearing left and right end prDNA units are encapsulated into virions.
Conclusions: In this study, we have determined the complete genome sequence of the BAC-cloned BoHV-4 V.test
strain and identified genome organization features that could be important in other herpesviruses.
Background
Gammaherpesviruses are archetypal persistent viruses
which are ubiquitous in both human and animal popula-
tions. The human gammaherpesviruses, Epstein-Barr
virus (EBV) and Kaposi’s Sarcoma-associated Herpes-
virus (KSHV), infect respectively some 90% [1] and 30%
[2] of human populations and cause several cancers
[2,3]. Although much effort has been invested on these
viruses, studies of EBV or KSHV are difficult to perform
directly because these viruses show limited lytic growth
in vitro and have no well-established in vivo infection
model. Related animal gammaherpesviruses are there-
fore an important source of information.
Bovine herpesvirus 4 (BoHV-4) belongs to the Gam-
maherpesvirinae subfamily, and to the Rhadinovirus
genus [4]. Similarly to its human counterparts, BoHV-4
was found to be widespread in all bovine populations
and to persist in the vast majority of individuals as a
lifelong, asymptomatic infection [5]. However, in some
circumstances, BoHV-4 has been associated with various
clinical symptoms such as skin lesions, respiratory dis-
eases, metritis, malignant catarrhal fever or tumors [5].
The virus was first isolated in Europe by Bartha et al.
from calves with respiratory diseases [6] and later in
North America by Mohanty et al. [7]. Besides cattle,
BoHV-4 has also been detected in a variety of rumi-
nants. In particular, BoHV-4 seems to be highly preva-
lent among wild African buffalo (Syncerus caffer)w h i c h
could be considered as the natural reservoir of the virus
[8-10]. Overall, more than 40 BoHV-4 strains have been
isolated across the world. These strains can be classified
in three groups: the European strains (or Movar 33/63-
like strains), the American strains (or DN 599-like
strains) and the African buffalo strains [9].
It is estimated that the taurine and buffalo strains
diverged around 730,000 years ago [9] and that the Eur-
opean and North American clades diverged around
260,000 years ago [9]. The genome of the BoHV-4 66-p-
347 North American strain has entirely been sequenced
[11]. However, the BAC-cloned reference strain V.test
[12,13] belongs to the European clade [9,14]. Previous stu-
dies suggested that the BoHV-4 V-test strain contains
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p-347 strain. Indeed, the nucleotide identity between the
two strains has been previously measured to be as low as
88% on the BORFB2 region [11]. However, the lack of a
complete genomic sequence for the V.test strain prevents
from drawing a general view concerning this divergence
level. Therefore, the low quality of the genomic informa-
tion hampers the use of the BAC-cloned BoHV-4 V.test
strain as a good model for studying gammaherpesvirus
biology. In this study, we have determined the genomic
sequence of the BoHV-4 V.test strain and analyzed its
overall differences with the available sequence of the
BoHV-4 66-p-347 strain [11,15]. The results obtained
highlighted important differences between BoHV-4 66-p-
347 and V.test strains. Moreover complete sequencing of
the BoHV-4 V.test strain also revealed genome features
potentially important in other herpesviruses.
Methods
BAC sequencing
BAC DNA was purified using Qiagen large-construct kit as
described by the manufacturer. The complete BAC cloned
viral genome of BoHV-4 V.test strain was determined by
pyrosequencing using the 454 GS FLX Titanium (Roche)
high-throughput sequencer and resulted in 48,967 reads of
an average read length of 265 nucleotides and a total of
12,997,275 bases. A targeted ABI-Sanger sequencing of
fragments of the prDNA region was also conducted using
the primers listed in Table 1. The raw 454 data has been
deposited in the NCBI Sequence Read Archive (SRA) data-
base with accession number SRA037246.
BoHV-4 genome LUR assembly
The reads were de novo assembled with gsAssembler
(Roche), where the E. coli genome was used as a contami-
nant to filter out cellular reads [16]. The filtering removed
1,167 contaminant cellular reads. The de novo assembly
yielded 11 contigs which were subsequently BLASTed
against 66-p-347’s long unique region (LUR) and polyre-
petitive DNA (prDNA) -accession numbers NC_002665
and AF092919- to define their relative positions [17]. Con-
tigs were assembled into a large scaffold using two pre-
viously published V.test sequences (accession numbers
Z46380 and Z46385 [18]) overlapping contig borders. A
careful comparison of the bordering contigs with the pre-
viously sequenced fragments showed a high percent iden-
tity (> 99.99%). After verification of the quality of the
assembly, the BAC sequence was removed and the gen-
ome sequence was annotated as detailed hereunder.
BoHV-4 genome prDNA assembly
The prDNA was determined by a hybrid 454/ABI-San-
ger strategy where 17 ABI-Sanger fragments of prDNA
were de novo assembled with the 454 reads. Briefly, in
order to correctly assemble the prDNA and to disentan-
gle different prDNA units, this second de novo assembly
was optimized for highly repetitive segments using
MIRA [19]. 454 reads and quality information were
extracted from the raw .sff file with ‘sff_extract’.T h e
base-calling and quality-calling for Sanger sequences
were inferred from the .ab1 raw chromatogram files
using ‘phred’ [20,21] and the sequences were quality-
trimmed using ‘lucy’ [22]. MIRA assembler (v 3.2.0) was
used to build an assembly of the V.test genome with the
following flags and options: “-job = denovo, genome,
accurate, sanger, 454 -highlyrepetitive -AS:klrs = no
454_SETTINGS -AS:urdcm = 1.1:ardml = 100’’.T h i s
assembly yielded a very large contig containing a com-
p l e t ep r D N Au n i t ,a n das e c o n dc o n t i gc o n t a i n i n ga n
incomplete unit bearing the prDNA/prDNA junction.
T h ec o m p l e t ep r D N Au n i tw a se x t r a c t e df r o mt h ef i r s t
contig and identified as being the last prDNA unit
before the LUR junction and noted prDNA-G following
Bublot et al. [14]. By analysing the contig bearing the
prDNA/prDNA junction in GAP4 [23], we determined a
518 bp fragment of the prDNA-inner unit (as named by
Bublot et al. [14]) bordered on the left by lower read
qualities and coverage, and on the right by the begin-
ning of a new prDNA unit. This end was joined to the
beginning (2,089 bp) of the prDNA-G unit in order to
obtain a complete prDNA-inner unit (2,607 bp). We
verified that this complete unit was compatible with
previously published information [14].
BoHV-4 genome annotation
All Open Reading Frames (ORFs) from all 6 frames
were retrieved from the complete genomic sequence
and matched against the Conserved Domain Database
[24] using the position-specific scoring matrices (PSSM)
based Reverse PSI-BLAST [25]. For all ORFs sharing the
same STOP and containing a PSSM match, the smallest
ORF containing the largest PSSM match was retained.
59 ORFs were thus considered evolutionarily conserved
and were annotated with the corresponding matching
conserved domains. Out of the 79 CDS from the pre-
viously published 66-p-347 strain, all 59 ORFs matched
previously annotated 66-p-347 ORFs. The 20 remaining
CDS were added by similarity to this strain and were
annotated as such. Repeat segments and special features
were annotated according to 66-p-347 if they were pre-
sent in V.test. The complete genome sequence contain-
ing the LUR, prDNA-G and prDNA-inner were
annotated and submitted to GenBank with respective
accession numbers: JN133502, JN133503 and JN133504.
Comparative genomics analysis of 66-p-347 and V.test
The LUR and prDNA sequences of the 66-p-347 strain
were joined into a complete genome (accession numbers
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LUR and prDNA-inner V.test sequences with ClustalW
2.0.10 [26]. Percent divergence, percent insertions and
deletions, and percent G+C content were computed (i)
along the alignment on a 100 bp sliding window of step 3
bp and (ii) on all individually aligned proteins. Analyses
and figures were conducted using R [27] and the seqinr
[28] package in combination with ad hoc programs written
in Python and using the Biopython libraries [29,30].
RT-PCR analysis
These experiments were performed as described else-
where [31]. Briefly, subconfluent monolayers of MDBK
cells were infected with BoHV4 V.test strain at a m.o.i.
of 1 PFU/cell. 18 hours after infection, cytoplasmic RNA
was extracted, purified and treated for RT-PCR. The
cDNA products were amplified by PCR using specific
primers listed in Table 1.
Results and discussion
BAC sequencing and genome assembly
Pyrosequencing of herpesviral genomes is often limited
by the high concentration of contaminating cellular
DNA [32]. We therefore prepared the BoHV-4 V.test
strain DNA from BAC maintained genomes and
sequenced it using a high-throughput pyrosequencing
approach [16]. This yielded 48,967 reads among which
47,800 were BoHV-4 specific (> 97% of the reads). After
assembly, the mean genome coverage was of the order
of 96×. In comparison to the whole genome sequencing
of another herpesvirus based on DNA isolated from
virus particles, which exhibited a 13× average base pair
coverage [32], our strategy showed a more than 7-fold
increase. This is probably mainly due to the high pro-
portion of viral to cellular reads present in our dataset.
Indeed, only 1,167 Escherichia coli contaminant reads
had to be discarded from the data, indicating less than
2.38% of contaminated reads, compared to the pre-
viously reported 62.72% contaminating cellular reads in
[32]. Our sequencing strategy based on a BAC cloning
approach, thus revealed itself very powerful in terms of
contamination and subsequent coverage.
V.test genome analysis and comparison to other BoHV-4
strains
The BoHV-4 genome has a B-type structure consisting
of a long unique region (LUR) flanked by several polyre-
petitive DNA units (prDNA). We assembled the
Table 1 Primers used in this study
name Sequence Coordinates according to Genbank
Bo1 Fwd 5’- ATGGAGGGTGATGGATTCATG-3’ 460-440
a
Bo1 Rev 5’- TTAAGGCCTCATTCCAGGAAG-3’ 272-292
a
Bo5 Fwd 5’- GCTACAGAAAATGGCCAGTAAAG-3’ 20366-20342
a
Bo5 Rev 5’- TCATGTCCTGAGTGGGTCTATG-3’ 19170-19191
a
Bo6 Fwd 5’- ATGGTCATCCTAAATGCTCAAG -3’ 20297-20318
a
Bo6 Rev 5’- TCACCTAGTGTTGCAACCCC -3’ 20497-20478
a
Bo7 Fwd 5’- ATGGAGACAATTTCCATAAACTG -3’ 20994-20972
a
Bo7 Rev 5’- CTAGCTGGGGTAGAGTGATC -3’ 20671-20690
a
ORF67.5 Fwd 5’- ATGGCTGATGGTGATGTTTTAG -3’ 93144-93123
a
ORF67.5 Rev 5’- TCAATGTTTGTCCAGAGCACT -3’ 92881-92901
a
Bo12 Fwd 5’- ATGGGGGCGCTATTTGGGC -3’ 97442-97460
a
Bo12 Rev 5’- TCAACTGATGAAACCCACCC -3’ 97525-97506
a
Bo13 Fwd 5’- ATGCGTCTCGATGGCAAGC -3’ 98838-98856
a
Bo13 Rev 5’- CTATGGTTGTTTTTTAAAGAAAATC -3’ 98981-98957
a
ORF75 Fwd 5’- ATGTATCCCAGATACAGTAACA -3’ 103606-103585
a
ORF75 Rev 5’- TTACATTTTATTTTTCAGACACCA -3’ 100274-100297
a
prDNA Fwd 1 5’- GGAGCCCAAAACCAAAAGAG -3’ 870-889
b
prDNA Rev 1 5’- CTCTTTTGGTTTTGGGCTCC -3’ 889-870
b
prDNA Fwd 2 5’- CGTAGGCCTCACATTCAGC -3’ 908-926
b
prDNA Rev 2 5’- GCTGAATGTGAGGCCTACG -3’ 926-908
b
prDNA Fwd 3 5’- CGAGAGATGGTTCTTGCACA -3’ 940-959
b
prDNA Rev 3 5’- TGTGCAAGAACCATCTCTCG -3’ 959-940
b
BAC Rev 5’- TTGCCAATCCCAAAAAGAAG -3’ 9859-9878
c
a according to Genbank JN133502 sequence (BoHV-4 V.test strain long unique region)
b according to Genbank JN133504 sequence (BoHV-4 V.test strain prDNA inner region)
c according to Genbank AY665170.1 sequence (pBeloBAC modified)
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a 108,241 bp sequence. The average G+C content is of
41.21%. This value as well as the G+C% variation
observed on Figure 1 is in agreement with previously
reported results on the 66-p-347 strain, namely on the
high G+C content of R2a region [11]. The observed-to-
expected CpG ratio is of 0.225 on the LUR and is com-
patible with the value measured on Bos taurus (0.234)
[33] suggesting (i) a high degree of methylation of CpG
nucleotides and (ii) similar methylation mechanisms act-
ing on the viral and cellular genome.
As expected, the nucleotide identity between our
assembled genome and previously published V.test
strain sequence data was of 99.55% in average, falling
into the ranges of comparison between 454 and Sanger
sequencing [34].
Compared to the 66-p-347 strain, the V.test strain had
previously shown divergence up to 12% on the region sur-
rounding BORFB2 (ORF 16, v-Bcl-2) [11]. However, the
lack of a complete genomic sequence for the V.test strain
prevented from drawing a general conclusion concerning
this divergence level. Compared to 66-p-347 strain, the
overall V.test nucleotide identity is high (99.1%), but
shows a large variability at the genome level (Figure 1). As
expected, the repetitive regions contained in the LUR (R1,
R2a and R2b) exhibit a high nucleotide divergence, up to
more than 40%, as well as large gaps (Figure 1). This indi-
cates that the very high divergence levels seem confined to
specific repetitive genomic regions. However, some rather
high divergence levels were also identified in other regions
(Figure 1) and namely in ORF-containing regions such as
ORF 10, Bo5, ORF 57, and ORF 68 region. We also note a
Figure 1 Map of the BoHV-4 V.test strain genome and divergence with the 66-p-347 strain sequence. The LUR of both strains have been
aligned. Genome features are represented in the upper part as grey and red oriented arrows. Red arrows represent genes with an in-frame STOP
codon, an early Methionine or a high divergence level in the V.test strain compared to 66-p-347. Dark (resp. light) grey arrows represent genes
with (resp. without) an evolutionarily conserved domain (see Methods). The exons of spliced genes are indicated under the given gene as thin
light-blue lines. Percent divergence is shown as a black-filled curve, percent insertions and deletions are shown as a blue-filled curve. Percent G
+C content is shown as a thin green curve, with the mean G+C content drawn as a thin horizontal green line. These percentages are measured
in a 100 bp window sliding 3 bp. Repeat regions (R1, R2a, R2b) are depicted as hatched areas. The oriLyt region is mapped as a light-grey area
within R2b and the conserved quasi-palindromic motif in the oriLyt region is indicated by a small vertical arrow.
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BoHV-4
ORF
Domain accession number Functional annotation Species distribution
a
ORF 3 COG0046, TIGR01735, TIGR01736, TIGR01739,
PF02769
Phosphoribosylformylglycinamidine (FGAM) synthase;
AIR synthase related protein
Eukaryota; Bacteria;
Archaea; Viruses
ORF 6 PF00747 ssDNA binding protein Herpesviridae
ORF 7 PF01366 Protein transporter activity Herpesviridae
ORF 8 PF00606 Surface glycoprotein Herpesviridae
ORF 9 COG0417, TIGR00592, PF00136, PF03104, SM00486 DNA polymerase type-B family Eukaryota; Bacteria;
Archaea; Viruses
ORF 10 PF04797 dUTPase Herpesviridae
Bo4 COG5183, SM00744 Protein involved in mRNA turnover and stability; zinc-
finger RING-variant domain
Eukaryota; Bacteria
ORF 16 SM00337 BCL (B-Cell lymphoma); contains BH1, BH2 regions Eukaryota; Bacteria; Viruses
ORF 17 PF00716 Serine-type endopeptidase activity Herpesviridae
ORF 18 PF03049 UL79 family Herpesviridae
ORF 19 PF01499 Virus penetration and capsid assembly Herpesviridae
ORF 20 PF01646 UL24 family Herpesviridae
ORF 21 PF00693, PF01712, PF08465 ATP binding; thymidine kinase activity;
phosphotransferase activity
Eukaryota; Bacteria; Viruses
ORF 22 PF02489 Virion associated envelope glycoprotein Herpesviridae
ORF 23 PF04682 BTRF1 protein conserved region Herpesviridae
ORF 24 PF03043 UL87 family Herpesviridae
ORF 25 PF03122 Structural molecule activity Herpesvirales
ORF 26 PF01802 Structural molecule activity Herpesvirales
ORF 29 PF02499, PF02500 Probable role in DNA packaging Herpesvirales
ORF 30 PF05338 Unknown function (DUF717) Gammaherpesvirinae
ORF 31 TIGR01234, PF03048 UL92 family; L-ribulokinase Herpesvirales;
Embryophyta
ORF 32 PF04559 DNA cleavage and packaging Herpesviridae
ORF 33 PF03044 Possible role in capsid maturation Herpesviridae
ORF 34 PF03038 UL95 family Herpesviridae
ORF 35 PF05852 Unknown function (DUF848) Gammaherpesvirinae
ORF 36 COG0515, PF00069, SM00220 ATP binding; protein kinase activity; Serine/
threonine protein kinase
Eukaryota; Bacteria;
Archaea
ORF 37 PF01771, PF09588 Exonuclease activity; DNA binding Eukaryota; Bacteria;
Viruses
ORF 38 PF10813 Unknown function (DUF2733) Herpesviridae
ORF 39 PF01528 Integral membrane protein Herpesviridae
ORF 40 PF03324 Helicase-primase complex associated protein Herpesviridae
ORF 41 PF05774 Helicase-primase complex components Gammaherpesvirinae
ORF 42 PF01677 UL7-like protein Herpesviridae
ORF 43 PF01763 Possible role in cleavage and packaging Herpesviridae
ORF 44 COG0507, PF02689 Helicase; ATP-dependent exoDNAse (exonuclease
V)
Eukaryota; Bacteria;
Viruses
ORF 46 COG0692, TIGR00628, TIGR03443, PF03167 Uracil DNA glycosylase Eukaryota; Bacteria;
Archaea; Viruses
ORF 47 PF11108 Glycoprotein L Herpesviridae
ORF 48 PF05734 Unknown function (DUF832) Herpesviridae
ORF 50 PF03326, PF04793 Early-intermediate transcription factors Gammaherpesvirinae
Bo10 PF05459, PF05812 Transcriptional regulator proteins Herpesviridae
ORF 53 PF03554 Highly polymorphic glycoprotein Herpesviridae
ORF 54 COG0756, TIGR00576, PF00692 dUTPase Eukaryota; Bacteria;
Archaea; Viruses
ORF 55 PF04533 U44 protein Herpesviridae
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the LUR compared to the 66-p-347 strain. Overall, these
differences in protein-coding region as well as in repetitive
regions that bear predicted microRNA coding sequences
[35] will require specific experiments to identify possible
links with observed phenotypic differences between
strains.
Conserved protein-coding genes
In order to develop an ab initio approach of gene anno-
tation, we extracted all possible ORFs in all 6 frames
from the complete genomic sequence of the BoHV-4 V.
test strain. On each of these ORFs, we ran a Reverse
PSI-BLAST [25] against all protein domains from the
Conserved Domain Database [24]. ORFs containing an
evolutionarily conserved domain were defined as the
smallest ORF containing the longest CDD match (see
Methods). This approach revealed 59 ORFs containing a
conserved CDD domain (Table 2). All 59 detected ORFs
corresponded to ORFs previously annotated in the 66-p-
347 strain (on a total of 79 ORFs listed in Table 3), indi-
cating that 75% of BoHV-4 ORFs contain conserved
domains. Most of these ORFs (37/59) contain domains
that are either conserved at different levels in the Her-
pesvirales (either gammaherpesvirinae, herpesviridae or
herpesvirales), or at a much larger scale that include
Eukaryota, Bacteria and Archaea (22/59) (Table 2). This
second set of genes might bear good candidates for
genes having been the stage of lateral gene transfer
events as observed for several herpesvirus genes [36]
such as the BoHV-4 Bo17 gene that encodes a homolo-
gue of the cellular core 2 beta -1,6-N-acetylglucosami-
nyl-transferase M [37]. These results will deserve further
studies to identify the evolutionary history responsible
for these observations.
Non-conserved protein-coding genes
The remaining 20 annotated ORFs were determined by
similarity to the 66-p-347 strain, and correspond for most
of them to ORFs unique to BoHV-4 as described previously
(Table 3) [11]. Some of these ORFs, however, contain odd
characteristics that needed to be investigated (Figure 2,
Additional file 1 Figures S1-9). Indeed Bo1, Bo6, Bo7, Bo12
and Bo13 genes of the BoHV-4 V.test strain present in-
frame STOP codons. Bo5 presents rather high divergency
levels and large insertions/deletions (> 5% of its coding
sequence as shown in Figure 2) compared to the genomic
sequence of the 66-p-347 strain. Moreover, ORFs 36, 67.5
and 75, which bear an evolutionary conserved domain, pre-
sent late methionines compared to the 66-p-347 annota-
tion. Indeed, in ORF 36 (see Additional file 1 Figures S5),
the smallest ORF containing an evolutionary conserved
domain is slightly shorter than the one annotated in 66-p-
347 and there is no evidence that the previously annotated
Table 2 Potential BoHV-4 V.test ORFs presenting conserved functional domains (Continued)
ORF 56 PF03121 UL52/UL70 DNA primase Eukaryota; dsDNA
Viruses
ORF 57 PF04633 BMRF2 protein Gammaherpesvirinae
ORF 59 PF04929 DNA replication accessory factor Gammaherpesvirinae
ORF 60 COG0208, PF00268 Ribonucleotide reductase Eukaryota; Bacteria;
Archaea; Viruses
ORF 61 COG0209, TIGR02504, TIGR02506, TIGR02510,
PF00317, PF02867
Ribonucleotide reductase Eukaryota; Bacteria;
Archaea; Viruses
ORF 62 PF03327 Capsid shell protein VP19C Herpesviridae
ORF 63 PF04523 Tegument protein U30 Herpesviridae
ORF 64 PF04843 Tegument protein, N-terminal conserved region Herpesviridae
ORF 65 PF06112 Capsid protein Gammaherpesvirinae
ORF 66 PF03117 UL49 family Herpesviridae
ORF 67 PF04541 Virion protein U34 Herpesviridae
ORF 67.5 PF03581 UL33-like protein Herpesviridae
ORF 68 PF01673 Putative major envelope glycoprotein Herpesviridae
ORF 69 PF02718 UL31-like protein Herpesviridae
ORF 71 PF01335, SM00031 Death effector domain Eukaryota; Viruses
ORF 75 COG0046, COG0047, TIGR01735, TIGR01736,
TIGR01739, TIGR01857, PF02769
Phosphoribosylformylglycinamidine (FGAM) synthase;
AIR synthase related protein
Eukaryota; Bacteria;
Archaea; Viruses
Bo17 PF02485 Core-2/I-Branching enzyme Eukaryota; Bacteria; Viruses
Conserved functional domains were determined for each BoHV-4 V.test ORF using METHOD and the domains accession numbers, functional annotation and the
species distribution were listed. When several domains were conserved, the annotations were either merged when possible or juxtaposed. Domains present in
herpesviridae conserved gene families are highlighted in bold (from Fu, 2008). (PFxxx: Pfam Accession Number; SMxxx: SMART Accession Number; COGxxx: COG
Accession Number; TIGRxxx: TIGRFam Accession Number).
a Major taxonomic groups.
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BoHV-4
ORF
Strand Start
a Stop
a HHV-8
homologue
b
HHV-1
homologue
c
Annotation and comments
Bo1 - 272 460 –– Early in-frame STOP codon
ORF 3 + 441 4307 –– BORFA1; v-FGAM-synthase
Bo2 + 4435 4638 ––
Bo3 + 5072 5299 ––
ORF 6 + 5703 9107 ORF 6 UL 29 single-stranded DNA-binding protein MDBP
ORF 7 + 9112 11190 ORF 7 UL 28 transport protein
ORF 8 + 11180 13804 ORF 8 UL 27 glycoprotein B
ORF 9 + 13944 16961 ORF 9 UL 30 DNA polymerase
ORF 10 + 17057 18337 ORF 10 – BORFB1
Bo4 - 18604 19101 –– short ORF of immediate early transcript 1
Bo5 - 19170 20355 K5 – long ORF of immediate early transcript 1
Bo6 + 20297 20590 –– Early in-frame STOP codon
Bo7 - 20670 20994 –– Disrupted frame
Bo8 + 21318 21521 –– overlapping with late 1.7 kb RNA
ORF 16 + 22967 23647 ORF 16 – BORFB2; v-Bcl-2 protein
ORF 17 - 23710 25260 ORF 17 UL 26 capsid protein
ORF 18 + 25259 26077 ORF 18 –
ORF 19 - 26029 27705 ORF 19 UL 25 tegument protein
ORF 20 - 27407 28219 ORF 20 UL 24
ORF 21 + 28203 29540 ORF 21 UL 23 thymidine kinase
ORF 22 + 29551 31674 ORF 22 UL 22 glycoprotein H
ORF 23 - 31671 32873 ORF 23 –
ORF 24 - 32851 35109 ORF 24 –
ORF 25 + 35099 39220 ORF 25 UL 19 major capsid protein
ORF 26 + 39256 40170 ORF 26 UL 18 capsid protein
ORF 27 + 40184 40829 ORF 27 –
Bo9 + 40831 41130 ––
ORF 29 - 41154 46328 ORF 29 UL 15 cleavage/packaging protein
ORF 30 + 42306 42548 ORF 30 –
ORF 31 + 42482 43123 ORF 31 –
ORF 32 + 43069 44439 ORF 32 UL 17 viral DNA cleavage/packaging protein
ORF 33 + 44432 45430 ORF 33 UL 16
ORF 34 + 46327 47313 ORF 34 –
ORF 35 + 47285 47758 ORF 35 –
ORF 36 + 47787 48950 ORF 36 UL 13 kinase
ORF 37 + 48958 50427 ORF 37 UL 12 alkaline exonuclease
ORF 38 + 50379 50585 ORF 38 –
ORF 39 - 50652 51761 ORF 39 UL 10 glycoprotein M
ORF 40 + 51877 53247 ORF 40 UL 8 helicase-primase complex component
ORF 41 + 53360 53881 ORF 41 – helicase-primase complex component
ORF 42 - 53873 54748 ORF 42 UL 7
ORF 43 - 54525 56375 ORF 43 UL 6 capsid protein
ORF 44 + 56323 58701 ORF 44 UL 5 helicase
ORF 45 - 58805 59530 ORF 45 –
ORF 46 - 59530 60291 ORF 46 UL 2 uracil-DNA-glycosidase
ORF 47 - 60309 60731 ORF 47 – glycoprotein L
ORF 48 - 60838 62382 ORF 48 –
ORF 50 + 62586 65179 ORF 50 – immediate early transcript 2; R transactivator protein
ORF 49 - 62600 63499 ORF 49 –
Bo10 + 65696 66595 – UL 54 glycoprotein gp80
ORF 52 - 66621 67007 ORF 52 –
Palmeira et al. Virology Journal 2011, 8:406
http://www.virologyj.com/content/8/1/406
Page 7 of 14methionine is the correct one. However, comparison with
homologous genes in other rhadinoviruses suggests that
the start codon proposed in the 66-p-347 annotated
sequence is the most likely. In ORF 67.5 (see Additional
file 1 Figures S6), there is a point substitution in the 66-p-
347 annotated ATG leading to the identification of a subse-
quent ATG as the V.test methionine. Finally, ORF 75 pre-
sents a small phase-disrupting indel in its 5’ end (see
Additional file 1 Figures S9), leading to the absence of the
66-p-347 annotated methionine in the V.test strain. All
these annotated genes requested therefore an investigation
of their transcription in mRNA products.
As these sequence properties could be specific to the
BAC clone of the BoHV-4 V.test strain, we investigated
the transcription of these genes on MDBK cells infected
with the BoHV-4 V.test WT strain as described in the
methods. The primers used are described in Table 1
and highlighted in Additional file 1. For all couple of
primers, cDNA from BoHV-4-infected MDBK cells gave
rise to the expected PCR products (Figure 3). The
absence of contaminant viral DNA in the mRNA pre-
parations was confirmed by a lack of PCR product with-
out reverse transcriptase. The size of the Bo5 RT-PCR
product was also consistent with its known mRNA spli-
cing (868 bp rather than 1140 bp). Moreover, the
sequences of these RT-PCR products were in agreement
with the BoHV-4 V.test sequence derived from our BAC
cloned genome (data not shown). Therefore, we can
conclude that all these coding sequences are transcribed
during BoHV-4 infection of MDBK cells. However,
further investigation is needed to determine the pre-
sence of proteins and ensure their accurate annotation.
BoHV-4 V.test replication origin
A large region containing the potential lytic replication
origin (oriLyt) of the BoHV-4 66-p-347 strain was
Table 3 Potential BoHV-4 V.test ORFs and homologues to HHV-8 and HHV-1 (Continued)
ORF 53 - 67073 67345 ORF 53 –
ORF 54 + 67414 68262 ORF 54 UL 50 dUTPase
ORF 55 - 68321 68923 ORF 55 –
ORF 56 + 68887 71418 ORF 56 UL 52 DNA replication protein
ORF 57 + 71512 72870 ORF 57 – possible post-transcriptional transactivator
ORF 58 - 73294 74346 ORF 58 –
ORF 59 - 74360 75535 ORF 59 – DNA replication protein
ORF 60 - 75688 76605 ORF 60 UL 40 ribonucleotide reductase small subunit
ORF 61 - 76639 79020 ORF 61 UL 39 ribonucleotide reductase large subunit
ORF 62 - 79002 80021 ORF 62 UL 38 assembly/DNA maturation protein
ORF 63 + 79978 82797 ORF 63 – tegument protein
ORF 64 + 82812 90488 ORF 64 UL 36 tegument protein
ORF 65 - 90504 90896 ORF 65 – capsid protein
ORF 66 - 90893 92167 ORF 66 –
ORF 67 - 92107 92877 ORF 67 UL 34 tegument protein
ORF 67.5 - 92881 93144 ORF 67.5 UL 33 Disrupted (late) methionine
ORF 68 + 93155 94504 ORF 68 UL 32 probable glycoprotein
ORF 69 + 94512 95405 ORF 69 UL 31
Bo11 - 96158 96703 ––
Bo12 + 97442 97684 –– Early in-frame STOP codon
ORF 71 - 98328 98876 K13/ORF 71 – BORFE2; v-FLIP
Bo13 + 98838 98983 –– Disrupted frame
ORF 73 - 99022 99783 ORF 73 – BORFE3, LANA homologous
ORF 75 - 100274 103606 ORF 75 – Disrupted (late) methionine; tegument protein/v-FGAM-
synthetase
Bo14 - 104273 104785 ––
Bo15 - 105724 106038 ––
Bo16 + 106225 106494 ––
Bo17 + 106681 108003 –– viral beta-1,6-N-acetylglucosaminyltransferase
a Positions of the respective ORFs of BoHV-4 on the LUR sequence. These are given from the first nucleotide of the start codon ATG to the last nucleotide of the
stop codon.
b Correspondance to HHV-8 genes is according to Zimmermann (2001).
c Correspondance to HHV-1 genes was based on the presence of conserved domain with a BoHV-4 gene. Genes containing evolutionary conserved domains are
highlighted in bold italic. The genes conserved in Herpesviridae are highlighted in bold (from Fu, 2008).
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Page 8 of 14determined by Zimmermann et al [11]. Based on this
information, we mapped this region on the V.test gen-
ome (Figure 1). This region contains Bo12, the R2b
region and partially overlaps with Bo11. Compared to
the 66-p-347 strain sequence, the corresponding region
in the V.test genome is highly divergent (Figure 4).
Although this region shows high divergence rates, we
expected the replication origin to be conserved between
the two BoHV-4 strains. Previous work on other herpes-
viruses has identified in oriLyt the presence of palindro-
mic motifs essential for viral replication [38-40]. When
we compared the potential region containing oriLyt in
the two strains, a single conserved palindromic region
was observed (AATCCAGGCCCCTGATTGGTA-
GATTGC TGAAAGCCAATCAGGGGCCTGGATT,
Figure 4). Interestingly, this region forms a perfect hair-
pin structure (Figure 4B) that resembles DNA structures
formed at other herpesvirus origins [41,42] and may
therefore represent a common secondary structure used
by all herpesvirus family members during the initiation
of DNA replication. In the future, this structure will be
tested as a candidate for an essential oriLyt replication
motif.
BoHV-4 V.test polyrepetitive DNA
In the BAC clone, previous restriction profiles had
determined a hypermolar prDNA band indicating that
the BAC contained several prDNA units [12]. There-
fore, the major pitfall in the assembly of the BoHV-4
V.test strain was the determination of the prDNA
sequence. Indeed, (i) the higher per base coverage on
this region due to repetition of prDNA units, (ii) the
high GC content, along with (iii) the presence of sev-
eral long repeats within the prDNA and (iv) the varia-
bility observed between prDNA units [14] made it
extremely difficult to resolve and assemble with
Figure 2 Proteins in V.test: divergence with the previously published 66-p-347 strain. Percentage divergence and percentages indels on
the aligned amino-acid sequences are represented as, respectively, black and light-blue bars. The dotted black line represents a 5% threshold.
Genes containing an evolutionarily conserved domain (see Methods) are represented on a light-grey background. Previously annotated genes
presenting in the V.test strain an in-frame stop codon, a late Methionine or large divergence levels compared to the 66-p-347 strain are
indicated in red.
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Page 9 of 14pyrosequencing data alone. Interestingly, it has been
shown for several rhadinoviruses that the left junction
between the prDNA and the LUR is the site of genome
rearrangements and that sequences of the prDNA are
found within the first base pairs of the LUR. These
properties make this region very difficult to sequence
[43-47].
Therefore, we adopted a hybrid strategy consisting in
adding some ABI-Sanger reads (with the primers
described in Table 1) to guide the 454 assembly on the
prDNA region (see Methods).
Bublot, et al. [14] described the different prDNA unit
variants present in BoHV-4 V.test, and namely the dif-
ferences between prDNA units. Firstly, the prDNA units
vary according to the number of repetitions of a ~200
bp Pst-I bordered fragment. Secondly, the last prDNA
before the prDNA/LUR junction (prDNA-G) displays a
different ending than the inner prDNA units [14]. Our
method allowed us to disentangle the repeats and to
assemble a contig containing a whole prDNA unit
(2,440 bp) along with the left prDNA-LUR junction.
This prDNA unit, corresponding to prDNA-G following
Bublot et al. [14], was extracted from the contig and
annotated. A second contig from this hybrid assembly
yielded the prDNA/prDNA junction. The presence of
the prDNA/prDNA junction in our assembly confirmed
the presence of at least two prDNA units in our BAC
clone and allowed us to build a complete prDNA-inner
unit (see Methods). The assembled prDNA-G and inner
prDNA units have sizes of 2,440 bp and 2,607 bp
respectively. Both these units are in agreement with
their previously published restriction maps [14].
Specifically, we showed that, comparatively to the 66-
p-347 strain, the V.test prDNA-inner unit presents sev-
eral indels including two large indels in the repetitive
PstI region (Figure 5). This PstI-rich repetitive region
s e e m st ob et h eo n ep r e s e n t i n gt h em o s tv a r i a t i o na si t
also presents comparatively large differences between
prDNA units within the same strain. Indeed, Bublot et
al. [14] roughly determined the size of the V.test major
prDNA-inner unit to be around 2,650 bp due to the
presence of 4 repetitions of the two small PstI bordered
fragments.
Figure 4 Prediction of BoHV-4 V.test OriLyt. A. Alignment of the V.test strain (above) and 66-p-347 strain (below) regions predicted to contain
the OriLyt in the 66-p-347 strain. The differences observed in the alignment are highlighted in light grey. The predicted potential OriLyt is
highlighted in dark grey. B. The predicted secondary structures of the top (+) and bottom (-) strands of the predicted BoHV-4 OriLyt sequence
were analyzed using the Vienna RNA website program RNAfold with DNA parameters. The predicted free energy (ΔG) of each structure is given,
as well as the positional entropy of each nucleotide.
Figure 3 RT-PCR amplification of the coding regions of the
genes Bo1, Bo5, Bo6, Bo7, ORF67.5, Bo12, Bo13 and ORF75 of
the BoHV-4 V.test strain. Subconfluent monolayers of MDBK cells
were infected with BoHV4 V.test strain at a m.o.i. of 1 PFU/cell. 18
hours after infection, cytoplasmic RNA was extracted, purified and
treated for RT-PCR. The cDNA products were amplified by PCR using
specific primers listed in Table 1.
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small PstI-bordered fragments make up a fragment of
186 bp and that these are indeed repeated 4 times
(Figure 6). In the prDNA-inner unit, we determined
that the last PstI-bordered fragment is actually a varia-
tion of the 186 bp fragment where the inner Pst-I site
is slightly modified (Figure 6). Therefore, the rough
200 bp size discrepancy between the prDNA-G (2,440
bp) and the prDNA-inner units (2,607 bp) is due to
the presence of a slightly modified repetition of the
previous segment. These results are compatible with
the restriction profiles presented in Bublot et al.[ 1 4 ]
as detailed by the positions of several restriction sites
on Figure 6.
In addition to the variations in the PstI-bordered
repetitions, one of the majord i f f e r e n c e sb e t w e e nt h e
prDNA-inner units and the prDNA-G lies in their 5’
end. Indeed, the prDNA-inner contains a conserved
pac-2 cleavage/packaging signal in its right terminal
region, which is not the case of prDNA-G (Figure 6).
Both units however, possess a conserved pac-1 clea-
vage/packaging signal in their left terminal region.
Interestingly, the pac-1 and pac-2 cleavage and packa-
ging signals show a good conservation between 66-p-
347 and V.test’s inner units, despite the presence of
these signals in a repeated region bearing high diver-
gence levels. Broll et al. [15] have determined, by
transient cleavage/packaging assay, that a single
prDNA unit is sufficient for cleavage and packaging.
However, from the absence of a conserved pac-2
motif in the prDNA-G, we suggest that, even if a sin-
gle inner prDNA unit is indeed sufficient for cleavage
and packaging, the prDNA-G alone would not suffice.
This would therefore indicate that two prDNA units
at least are necessary in the context of naturally
occurring BoHV-4 genomes for correct cleavage and
packaging. The packaging of herpesvirus genomes is
still not fully understood, however, detailed studies in
herpes simplex virus type 1 (HSV-1), human and
murine cytomegaloviruses (HCMV and MCMV) have
Figure 5 The BoHV-4 inner prDNA units contain conserved cleavage/packaging signals. Alignment of the prDNA-inner units from V.test
strain (above) and 66-p-347 strain (below). The differences observed in the alignment are highlighted in grey. The cleavage/packaging signals
pac-1 and pac-2 are represented in boxes, and their composing C-rich, G-rich, GC-rich and T-rich units are indicated. PstI, EcoRI, SstII, BamHI
restriction sites are represented in coloured font.
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and suggested the following general mechanism by
which concatemers are cleaved and packaged [48-50].
Firstly, the T-box of the pac-2 signal is essential for
the cleavage that initiates DNA packaging. Cleavage
occurs at a fixed distance from the pac-2 T-box, and
the resulting end that contains the pac-2 GC-box and
other cis acting elements is inserted into the procap-
sid. Packaging is therefore directional and proceeds
from pac-2 towards the pac-1 terminus [48]. A second
cleavage event, directed by pac-1, then terminates
DNA packaging. If we apply this model to BoHV-4,
the divergence of the pac-2 signal in prDNA-G,
namely the absence of a T-box, indicates that it is not
af u n c t i o n a lpac-2 initiation signal. As the genome
packaging is directional from pac-2 to pac-1 (there-
fore, from the right to the left end of the genome),
the lack of a pac-2 initiation signal in prDNA-G
ensures that no packaging would lead to a remaining
concatemer lacking a left end prDNA. This would
therefore guarantee that genomes bearing at least one
left and one right end prDNA unit are encapsulated
into virions. This model and its implications will
require further investigations in the future.
Conclusions
BAC-cloning of the BoHV-4 V.test strain has greatly
facilitated the use of this virus as a model for human
pathogenic gammaherpesviruses. However, until now,
t h ec o m p l e t eg e n o m es e q u e n c eo ft h i ss t r a i nw a s
unavailable. In this study, we have determined the
complete genome sequence of the BoHV-4 V.test
strain. In comparison with the previously sequenced
66-p-347 strain, we identified important differences
in 9 potential open reading frames. Moreover,
sequence analyses allowed us to identify genome fea-
tures that are potentially important for viral replica-
tion. All together, these results should have
implications for the study of BoHV-4 and herpes-
viruses in general.
Figure 6 The prDNA-G unit does not present a complete pac-2 cleavage/packaging signal. Alignment of the prDNA units from V.test
strain (prDNA-inner above and prDNA-G below). The differences observed in the alignment are highlighted in grey. The cleavage/packaging
signals pac-1 and pac-2 are represented in boxes, and their composing C-rich, G-rich, GC-rich and T-rich units are indicated. PstI, EcoRI, SstII,
BamHI restriction sites (here PstI) are represented in coloured font. One modified PstI restriction site in the prDNA-inner is also highlighted to
indicate the divergence between the fragments composing both units.
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Additional file 1: Alignments of the nucleotide and predicted amino
acid sequences of Bo1 (Figure S1), Bo5 (Figure S2), Bo6 (Figure S3),
Bo7 (Figure S4), ORF36 (Figure S5), ORF67.5 (Figure S6), Bo12
(Figure S7), Bo13 (Figure S8) and ORF75 (Figure S9) of BoHV-4 V.
test and 66-p-347 strains. Nucleotide sequences aligned at the amino-
acid level are represented for BoHV-4 V.test (red) and 66-p-347 strains
(blue). Mismatching residues are highlighted in a shaded grey box. The
predicted amino-acid sequences are respectively drawn for V.test and for
66-p-347 above and below the nucleotide sequences. The STOP codons
are highlighted by small colored boxes. The annotated Methionine are
highlighted in bold font. In the Bo5 sequence, introns are represented by
boxes. Positions of the specific primers used in Figure 3 are underlined.
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